{"slideshow_credits": null, "snippet": "Experts say that doctors, despite the dangers, often keep patients on high-strength painkillers known as opioids for years without properly checking to see if their conditions improve.", "abstract": "Medical professionals are trying to curtail the overprescribing of high-strength painkillers known as opioids, which represent the most widely prescribed class of medications in the United States; Washington State lawmakers imposed new requirements on doctors to refer patients taking high dosages of opioids, which include hydrocodone, fentanyl, methadone and oxycodone, the active ingredient in OxyContin, for evaluation by a pain specialist if their underlying condition is not improving.", "section_name": "Health", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Barry", "role": "reported", "lastname": "MEIER", "rank": 1, "organization": ""}], "original": "By BARRY MEIER", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/04/09/health/opioid-painkiller-prescriptions-pose-danger-without-oversight.html", "lead_paragraph": "Experts say that doctors, despite the dangers, often keep patients on high-strength painkillers known as opioids for years without properly checking to see if their conditions improve.", "headline": {"seo": "Opioid Painkiller Prescriptions Pose Danger Without Oversight", "main": "Tightening the Lid on Pain Prescriptions", "print_headline": "Tightening the Lid On Pain Prescriptions"}, "_id": "53f582be38f0d87ef470e657", "word_count": "2603", "multimedia": [{"height": 397, "url": "images/2012/04/09/us/JP-PAIN-1/JP-PAIN-1-articleLarge.jpg", "legacy": {"xlarge": "images/2012/04/09/us/JP-PAIN-1/JP-PAIN-1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "397"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2012/04/09/us/JP-PAIN-1/JP-PAIN-1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2012/04/09/us/JP-PAIN-1/JP-PAIN-1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2012-04-09T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Pain-Relieving Drugs", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Doctors", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Drug Abuse and Traffic", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Washington (State)", "name": "glocations", "is_major": "Y", "rank": "4"}, {"value": "Pain", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "OxyContin (Drug)", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Purdue Pharma", "name": "organizations", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}